Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 10.66%, which has investors questioning if this is ...

Teva Pharmaceutical Industries (NYSE:TEVA) recently received FDA acceptance of its supplemental Biologics License Application ...

Israel-based Teva Pharmaceuticals industries (NYSE: TEVA) today revealed two important updates reflecting its commitment to ...

This month, the Focus List additions are Teva Phar Inds Lt (TEVA); SAP SE (SAP); 3M Co. (MMM); Meta Platforms Inc (META) and the Focus List deletions are Crowdstrike Holdings Inc (CRWD); Lilly(Eli ...

Pharmaceuticals announced that the U.S. Food and Drug Administration has accepted its supplemental Biologics License Application ...

EPYSQLI is designed to treat gMG in adults who are anti-acetylcholine receptor antibody positive.

Croatian drug maker Pliva, part of Israeli-based pharmaceuticals manufacturer Teva Group, said on Friday its CFO Nikolina ...

EPYSQLI ® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, ...

Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.

Epysqli is used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized myasthenia ...

Analysts at Zacks Research raised their FY2025 earnings per share estimates for shares of Teva Pharmaceutical Industries in a ...